CMO/CDMO Biotechnology Market Analysis Reveals Key Players Strengthening Bioproduction Networks
The global CMO/CDMO biotechnology market is witnessing an era of robust growth, driven by the increasing dependence of pharmaceutical and biopharmaceutical companies on outsourcing models for the development and production of innovative biologics and advanced therapies. Valued at US$74.0 billion in 2025, the market is projected to reach US$168.9 billion by 2032, expanding at a strong compound...
0 Comments 0 Shares 5 Views 0 Reviews